DIALYSIS · CCN 552650
DaVita Sanger Sequoia Dialysis
SANGER, CA 93657
DialysisProfitDaVita
$4.7M
TOTAL REVENUE
3.6%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2025)
- Net patient revenue
- $4.7M
- Total costs
- $4.6M
- Operating income (rev − costs)
- $168K
- Operating margin
- 3.6%
- Total charges
- $4.8M
- Total treatments
- 14,203
- Dialysis stations
- 16
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
13 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 1.69 | 56 | — |
Fistula Rate DFC_FISTULA_RATE | 71.3 | 111 | — |
Five Star Rating DFC_FIVE_STAR | 4 | — | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 0.46 | 46 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 2 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 97.8 | 77 | — |
Standard Infection Ratio (SIR) DFC_INFECTION_RATIO | 0.65 | — | — |
Percentage of Adult Patients with Long Term Catheter in Use DFC_LONG_CATHETER | 18 | 111 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 23.4 | 315 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 20.6 | 86 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 17.6 | 42 | — |
Standardized ED Visits Ratio DFC_SEDR | 1.42 | 36 | — |
Patient Transfusion Rate DFC_TRANSFUSION_RATE | 30.4 | 34 | — |